# LIDOCAINE HCI

NDC: 51662-1233
Generic name: LIDOCAINE HCI
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL
Marketing started: 20190628

FDA application: ANDA040078

## Active ingredients

- LIDOCAINE HYDROCHLORIDE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1233"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1233
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c63be55-5de4-7f72-e053-2995a90a102e